泰勝風能(300129.SZ):決定向北京泰勝提供不超7000萬元財務資助
格隆匯5月28日丨泰勝風能(300129.SZ)公佈,公司於2021年5月28日召開的第四屆董事會第十六次會議和第四屆監事會第十三次會議審議通過了《關於對控股子公司提供財務資助的議案》,決定以自有資金向控股子公司泰勝風能(北京)科技發展有限公司(“北京泰勝”)提供人民幣最高額度不超過7000萬元的財務資助,用於其自身運營及投資泰勝風能(嵩縣)新能源開發有限公司(“嵩縣泰勝”),資助期限為5年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.